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Abstract 
HMG-CoA reductase inhibitors, better known as statins, are used to lower the amount of 
cholesterol in the blood. Due to this action, popular opinion favored the idea that these 
medications be administered in the evening, when the liver synthesizes the most cholesterol. The 
paradigm has shifted, though, and new ideas on when to administer these drugs have come up. 
Unfortunately, there is no research supporting any new administration time and it appears that 
the old favored way never really had any research behind it to begin with. This has negatively 
impacted the healthcare field, both providers and patients alike. Providers have been left to 
interpret and practice based on the results of contradicting research data and patients have been 
receiving education that could be incorrect. And in the age of patients receiving care at multiple 
institutions, patients also run the risk of hearing differing information about the same topic, 
which can lead to confusion and decreased medication compliance. In order to fully resolve this 
issue, more research on the administration time of statins is needed.  
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The Effects of Limited Research on HMG-CoA Reductase Inhibitors on Medication 
Administration and Patient Education in the Inpatient Setting 
 
 “Approximately 80 million Americans have cardiovascular disease” (Montfort, 2013, np). 
Statins are a form of medication used to treat the plaque buildup seen in this disease process 
(Montfort, 2013). With this disease currently ailing so many millions of people, it is no wonder 
why statins are so important. Unfortunately, there is a distinct lack of research regarding the 
administration time of statins. The healthcare realm once thought that these medications should 
be administered at night but thoughts have shifted over the years, except not on one set idea and 
there is not enough research to back any one claim.  
 
This has had negative impacts on the healthcare world. Hospitals and providers have been left to 
interpret their own variations of this differing research and consequently patients have been 
receiving the fallout; neighboring hospitals are educating patients differently on the same topic. 
With conflicting information, patient compliance to the statin therapy may, in turn, decrease 
adherence (Abbott, 1998).  
 
To our knowledge, no review has addressed the negative impacts that the lack of research 
surrounding statins and their administration time have on patient education. Therefore, in this 
review, we addressed the current literature on statins and examined the benefits of patient 
education.  
Methods 
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Initially, the team met to identify the research questions. The team consisted of a nursing student 
and nursing professor, both of which had prior experience with and background knowledge of 
HMG-CoA reductase inhibitors.  The nursing professor was trained in proper research methods.  
 
Secondly, research studies were found between September 2016 and February 2017. The 
following databases were used to conduct this review: UpToDate, CINAHL, PubMed, Elsevier 
and Google Scholar. The words listed below, along with synonyms, were the terms used in each 
database: 
Concepts relating to medications/health: statin, medication adherence, discrepancy, 
timing, five rights, compliance, HMG-CoA reductase inhibitors, cardiac, cardiovascular 
disease, lipid-lowering drugs, cholesterol, morning, evening, therapy, once daily 
medication 
 
Concepts relating to patients: patient education, safety, inpatient setting, standardized, 
benefits 
 
Due to the lack of research articles addressing the research question, no study design restrictions 
were used in order to maximize the number of topic-relevant articles. Upon reviewing studies, 
we searched through reference lists to see if there were any more relevant articles that could be 
used. Many of these studies had already been found during the initial search.  
 
After reviewing all of the articles, we selected the most relevant ones for our research topic. We 
initially started out with 14 research studies. Two of them were eliminated for redundancy. One 
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article was later eliminated for irrelevance. We then placed all of the studies into a chart (Table 
1. in Appendix A) detailing the author, year, summary of the study with results, database 
accessed, and date accessed.  
 
Upon completion of the chart, we went into the inpatient setting. We assessed the administration 
of statins on an orthopedic/neurosurgery unit at Hospital A for a period of 10 weeks and we 
assessed the nurses’ statin administration through a survey. The survey was sent to 10 nurses that 
were at least a Clinical Nurse II or higher. The survey was sent out once to each nurse in an 
individual e-mail. The survey was one question in length, seen below: 
 
Of the once-daily statins that are ordered for your patients, do you see them ordered to be 
administered in the morning or at night?  
 
From there we spoke to the Head of Pharmacy at Hospital A, who told us that statins are a 
nightly medication and that the computer system at Hospital A automatically categorizes them in 
a way so that they will always show up with the 2100 medications on a patient’s Medication 
Administration Record (MAR).  
 
We then spoke informally to a few nurses on the Heart Unit at Hospital A, who told us that 
statins are administered randomly on their unit and that it is more common for patients to have 
them administered in the morning rather than at night. We tried to get in touch with the nursing 
informatics officer at Hospital A, but achieved no response.  
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After re-evaluating all of our conflicting data from Hospital A, we decided to approach the topic 
from another angle. About three weeks later, we met with the Patient Education committee for 
the health system of Hospital A. It was there that we got the idea to look up the policies on statin 
administration at Hospital A.  
 
We were also granted the permission to look up the policy on statins at another hospital, Hospital 
B, to compare the two policies. Hospital A and Hospital B are within 40 miles of each other. 
These two hospitals are not within the same health system.  
 
Results 
 
This review includes 11 research based studies and data from two hospitals.   
 
Medication discrepancies are best defined as differences in documented medication regimens 
between care settings i.e. at home, outpatient setting, inpatient setting (Quelennec, Beretz, Paya, 
Blickle, Gourieux, Andres, Michel, 2013). This poses a threat to patient safety and optimal 
patient outcomes because, as the patient’s standard medication regimen is not assessed, sub or 
supra-therapeutic doses of medications could be administered to the patient (Stitt, Elliott, 
Thompson, 2011).  
 
Cardiovascular drugs are among the top three most frequently documented medications involved 
in medication discrepancies (Quelennec, et. al., 2013). Moreover, statins were found to be the 
most common medications out of these cardiovascular drugs involved in these reported 
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medication discrepancies (Quelennec, et. al., 2013). “For over 40 years, statins have been used as 
a means of both primary and secondary cardiovascular disease treatment” (Sirtori, 2014, p.10). 
“Statins, or HMG-CoA Reductase inhibitors, work by blocking a step in the cholesterol synthesis 
pathway, which significantly lowers production of cholesterol, lowers the hepatic-cholesterol 
concentration, and leads to the increased expression of LDL-receptors in the liver membranes 
yielding a higher uptake of cholesterol from the blood (Sirtori, 2014, p. 7)”. Research has also 
shown that statins “stabilize cholesterol plaques in the vasculature by dissolving cholesterol 
crystals, which lessens the chance of an adverse cardiac event, such as a myocardial infarction or 
stroke” (Abela, Vedre, Janoudi, Huang, Durga, Tamhane, 2010, p. 1710).  
 
It is important to administer statins at the right time and at the same time daily in order to 
achieve the maximal lipid lowering effect (Kamal, 2011). In previous years, it was thought that 
all statins were to be administered in the evening (Wallace, Chinn, Rubin, 2003). This is based 
on the idea that statin administration should coincide with liver synthesis; the “liver synthesizes 
the most cholesterol when dietary intake is at its lowest, which, for most people, is during their 
sleep” (Wallace, et. al., 2003).  
 
The FDA, however, promotes administering statins based on the length of their individual half-
lives (Kamal, 2011).  As cholesterol is synthesized in the early morning hours, the FDA 
recommends that statins with a shorter half-life be taken in the evening (Kamal, 2011). “Statins 
with a shorter half-life include: lovastatin, simvastatin, and fluvastatin” (Kamal, 2011, p. 3). “For 
statins with a longer half-life, atorvastatin, pravastatin, and rosuvastatin, the FDA recommends 
day time administration” (Kamal, 2011, p. 3).  
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The results have been varied amongst the studies that have researched the effectiveness of 
administering statins at different times based on the length of their half-lives. Despite its longer 
half-life, Zhu, Zhou, Yan, and Yeng (2008) listed pravastatin as a medication to “always be 
administered in the evening when treating hypercholesterolemia” (p. 1562). When compared side 
by side, the lipid lowering effect of the statins with the longer half-lives was not more significant 
when administered in the morning as opposed to the evening (Plakogiannis & Cohen, 2007).  
 
Of significant importance to note is that, in at least one study, daily adherence to the medication 
was higher when clients were on an evening regimen versus a morning regimen, regardless of the 
statin itself (Calvo, Lopez, Hermida, Ayala, Covelo, Rodriguez, Romero, Fontao, Soler, 2005). 
Adherence to cardiovascular treatment is necessary to retain a healthy lifestyle.  “Non-adherence 
to statins has been associated with worsening hypertension, diabetes, myocardial infarction and 
stroke” (Frishman, 2007, p. 257). 
 
The health system for Hospital A did not have a preference for the administration time of their 
statins. According to the survey sent out via e-mail to 10 nurses on an orthopedic/neurosurgery 
unit at Hospital A, the administration time of daily statins varies. 4 nurses stated that they see the 
orders for once-daily statins to be administered at night. 3 nurses stated that they see the orders 
for once-daily statins to be administered in the morning. 2 nurses stated that they see the orders 
for once-daily statins to be administered both in the morning and at night, depending on the 
ordering provider. One nurse did not respond to the survey.  
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The health system for Hospital B prefers to administer their statins with in the evening, but 
according to their policy on statin administration, they will alter their inpatient medication 
administration time if the manufacturer of the medication recommends an administration time. 
 
Patient education is the transfer of information from healthcare provider to patient (Abbott, 
1998). With a patient population that is growing more knowledgeable of their treatment and with 
patients receiving care at multiple facilities now, it is important to find out their baseline 
understanding of their care, as they may already have their own ideas of how things should be 
done (Abbott, 1998).  
 
Discussion 
 
It is interesting to note the dates of the studies in this literature review. The older studies, those 
around the early 2000s, claim that statins are more effective when taken at night. Towards the 
new decade, minds have shifted. During 2011, as seen in Kamal’s study, the FDA sponsored 
taking statins based on its half-life.  Before that, though, it seems that the healthcare world 
started questioning the nightly statin administration time, most likely between 2005 and 2010, as 
seen by the 2007 Plakogiannis study on half-lives and the 2008 Zhu study regarding pravastatin. 
So it seems that a whole new slew of research on the administration time of statins came to light 
during this time, but none of it was conclusive. This had an interesting effect on the healthcare 
setting, which are starting to play out now. 
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Take for instance, Hospital A. We have concluded that there is no set time for statin 
administration at Hospital A, despite the Head of Pharmacy’s claims. The nurses there 
administer their statins either at 0900 or 2100. Their patient education handouts regarding statins, 
though, say to “take regularly.” The nurses at Hospital B administer all of their statins at 2100. 
Their patient education handout regarding statins says to “take nightly.” This poses a potential 
problem. Since these two hospitals are within 40 miles of each other, it is highly likely that 
patients may receive treatment at both hospitals at some point in their life. If a patient is taking 
their statin nightly and goes in for treatment at Hospital A, they run the risk of being 
administered their medication at 0900. This medication discrepancy can affect adherence to the 
treatment due to confusion (Calvo et.al, 2005). The same goes for the patient taking a statin in 
the morning and going in for treatment at Hospital B. 
 
The data supporting Hospital A’s patient education handouts are from 2016. The data supporting 
Hospital B’s patient education handouts range from 2003-2007. Both materials were copyrighted 
in 2017.  
 
Due to the lack of conclusive research we have on the administration of statins, healthcare 
providers have not been able to carry out their treatment plans in the most effective manner. The 
more the provider knows, the more they can educate the patient and the more likely the patient 
will adhere to the treatment regimen (Abbott, 1998).  
 
Limitations 
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Limitations of this study include a lack of research on the topic. In general there are few studies 
addressing the administration time of statins and those that do address the administration time of 
statins contradict one another. The majority of these studies were also from the early 2000’s and 
could have held outdated information but due to the lack of research on this topic, there was no 
way to know what was and what was not outdated. We also only looked into the policies of two 
hospitals. Moreover, these two hospitals were in the same region. At both institutions, despite 
having access to the hospital-wide policies on statin administration, we only had access to see 
how the policies were implemented on one unit at each hospital. 
 
Recommendations 
 
Moving forward we recommend that statins be researched further in order to eliminate some of 
the discrepancies currently going on right now in the healthcare world. We also recommend that 
hospitals in close proximity work together as much as possible to not provide different patient 
medication experiences and different patient education materials in order to promote compliance, 
safety, and patient satisfaction.  
 
Conclusion 
 
This review has discussed various articles in regards to HMG-CoA reductase inhibitors, or 
statins, and the current lack of and contradictory research there is when it comes to the optimal 
time to administer these medications. Due to the research that is out there, healthcare 
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organizations and providers have struggled finding the best way to educate patients on statins, 
and policies on these medications have been shown to vary from institution to institution, even 
amongst institutions in close proximity, which can have negative impacts on patient medication 
compliance. The results of this study should encourage researchers to continue looking into 
statins and their therapeutic administration time.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HMG-CoA	REDUCTASE	INHIBITORS		 12	
References 	Abela,	G.,	Vedre,	A.,	Janoudi,	A.,	Huang,	R.,	Durga,	S.,	&	Tamhane,	U.	(2011).	Effect	of	Statins	on	Cholesterol	Crystallization	and	Atherosclerotic	Plaque	Stabilization.	American	
Journal	of	Cardiology,	107(12),	1710–1717.	doi:10.1016/j.amjcard.2011.02.336		Abbott,	S.	(1998).	The	Benefits	of	Patient	Education.	Gastroenterolgy	Nursing,	21(5),	207–209		Calvo,	C.,	Lopez,	J.,	Hermida,	R.,	Ayala,	D.,	Covelo,	M.,	Rodriguez,	M.,	Romero,	M.,	et	al.	(2005).	Administration	time-dependent	efficacy	of	statins	in	hyperlipidemic	patients	with	essential	hypertension.	American	Journal	of	Hypertension,	18(54).	doi:10.1016/j.amjhyper.2005.03.525		Frishman,	W.	(2007).	Importance	of	medication	adherence	in	cardiovascular	disease	and	the	value	of	once-daily	treatment	regimens.	Cardiology	Review,	15(5),	257–263.	doi:10.1097/CRD.0b013e3180cabbe7		Kamal,	S.	(2011).	Effects	of	single-dose	morning	and	evening	administration	of	pravastatin	on	antioxidant	markers	in	cholesterol-fed	rabbits.	Journal	of	Experimental	
Pharmacology,	3(51),	51–58.	doi:10.2147/JEP.S19449		
Montfort, E. (2013). Fibrates and Cardiovascular Outcomes. Topics in Evidence-Based 
Pharmacy Practice. New York, New York: The McGraw-Hill Companies. Retrieved 
from http://accesspharmacy.mhmedical.com/ 	Plakogiannis,	R.,	&	Cohen,	H.	(2007).	Optimal	Low-Density	Lipoprotein	Cholesterol	Lowering—	Morning	Versus	Evening	Statin	Administration.	Annals	of	
Pharmacotherapy	,	41(1),	106–110.	doi:10.1345/aph.1G659		Quelennec,	B.,	Beretz,	L.,	Paya,	D.,	Blickle,	J.,	Gourieux,	B.,	Andres,	E.,	&	Michel,	B.	(2013).	Potential	clinical	impact	of	medication	discrepancy	at	hospital	admission.		European	
Journal	of	Internal	Medicine	,	24(6),	530–535.	doi:10.1016/j.ejim.2013.02.007		Stitt,	D.,	Elliott,	D.,	&	Thompson,	S.	(2011).	Medication	discrepancies	identified	at	time	of	hospital	discharge	in	a	geriatric	population.	American	Journal	of	Geriatric	
Pharmacotherpay	,	9(4),	234–240.	doi:10.1016/j.amjopharm.2011.06.002		Sirtori,	C.	(2014).	The	pharmacology	of	statins.	Pharmacological	Research	,	88,	3–11.	doi:10.1016/j.phrs.2014.03.002		Wallace	,	A.,	Rubin,	G.,	&	Chinn,	D.	(2003).	Taking	simvastatin	in	the	morning	compared	with	in	the	evening:	randomised	controlled	trial.	British	Medical	Journal	,	327,	798.		
HMG-CoA	REDUCTASE	INHIBITORS		 13	Zhu,	L.,	Zhou,	Q.,	Yan,	X.,	&	Zeng,	S.	(2008).	Optimal	time	to	take	once-daily	oral	medications	in	clinical	practice.	International	Journal	of	Clinical	Practice,	62,	1560–1571.	doi:10.1111/j.1742-1241.2008.01871.x																																												
HMG-CoA	REDUCTASE	INHIBITORS		 14	
Appendix A 
Table 1. 
Author Article Title Year Database 
Used 
Accessed Summary 
Wallace, A., 
Chinn, D., Rubin, 
G. 
Taking simvastatin in the 
morning compared with 
in the evening: a 
randomized control trial  
2003 CINAHL 2-Sep-16 Simvastatin has been proven most 
effective when taken at night. 
Atorvastatin has no difference when taken 
at night or in am, possibly due to its 
longer half life.  
Calvo, C., Lopez, 
J., Hermida, R., 
Ayala, D., Covelo, 
M., Rodriguez, M., 
Romero, M., 
Fontao, M., Soler, 
R. 
Administration Time-
Dependent Efficacy of 
Statins in Hyperlidemic 
Patients With Essential 
Hypertension 
2005 GoogleScholar 2-Sep-16 When taken at night, statins are more 
effective than when taken at lunch or 
morning. Therapeutic compliance also 
increases when taken at night.  
Kamal, S.  Effects of single-dose 
morning and evening 
administration of 
pravastatin on 
antioxidant markers in 
cholesterol-fed rabbits 
2011 PubMed 7-Sep-16 t has been stated that statins with a longer 
half life are more effective when given in 
the morning. Although pravastatin has a 
longer half life, it is more effective when 
given at night.  
Frishman, W. Importance of 
medication adherence in 
cardiovascular disease 
and the value of once-
daily treatment regimens 
2007 PubMed 3-Oct-16 Adherence to statin therapy is critical in 
preventing poor outcomes. The number of 
daily doses has a positive relationship 
with adherence.  
Zhu, L.,Zhour, Q., 
Yan, F., Zeng, S. 
Optimal time to take 
once-daily oral 
medications in clinical 
practice 
2008 CINAHL 3-Oct-16 Statins with shorter half lives are more 
effective when given at night. Pravastatin 
should always be administered at night.  
Abela. G, Vedre, 
A, Janoudi, A., 
Huang, R., Durga, 
S., Tamhane U. 
Effects of Stains on 
Cholesterol 
Crystallization and 
Atherosclerotic Plaque 
Stabilization   
2011 CINAHL 3-Oct-16 Stains are proven to dissolve crystals in 
human plaques. It also changes the shape 
of the plaque (less pointed more blunt). 
These things together prevent plaque 
rupture.  
Stitt, D., Elliott, D., 
Thompson, S. 
Medication 
Discrepancies Identified 
at Time of Hospital 
Discharge in a  Geriatric 
Population  
2011 CINAHL 3-Oct-16 Medication discrepancies are related to 
the number of medications prescribed. 
They occur frequently in the elderly 
population. Reconciliation programs have 
started to pop up in 78% of hospitals 
Quelennec, B., 
Beretz, L., Paya, 
D., Blickle, JF., 
Gourieux, B, 
Andres, E., Michel, 
B. 
Potential clinical impact 
of medication 
discrepancy at hospital 
admission  
2013 CINAHL 3-Oct-16 Cardiovascular agents are among the 
most common drugs where medication 
discrepancies occur. One of the most 
common discrepancies was incorrect 
frequency of med admin.  
Sirtori, C. The pharmacology of 
statins 
2014 PubMed 3-Oct-16 Stains work by inhibiting HMG-CoA 
reductase. They act on a step in the 
synthesis of Cholesterol – the mevalonate 
pathway (step required for cholesterol 
synthesis in cells. 
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Plakogiannis, R., 
Cohen, H. 
Optimal Low-Density 
Lipoprotein Cholesterol 
Lowering— Morning 
Versus Evening Statin 
Administration  
2007 PubMed 5-Oct-16 Simavastatin is more effective when 
given in the morning. Lovastatin, 
Pravastatin and Rouvastatin showed an 
incease in lowered LDL levels when 
taken at night.  
Abbott, S The Benefits of Patient 
Education 
1998 PubMed 1-Feb-17 It is up to the nurse to ensure that patient 
education is carried out appropriately. 
Educating patients fully comes with many 
benefits such as increased patient 
satisfaction and increased medication 
compliance.  
 	
